There is a very high expression of certain proinflammatory cytokines, such as tumour necrosis factor α (TNFα), which is why the use of cytokine blocking drugs is used to treat many of these IMIDs (IBD, uveitis, psoriasis, PAs, and juvenile idiopathic arthritis/JIA) [21]. This evidence concerns the gene TNF and inflammatory bowel disease.